title: Synergistic effect of paclitaxel and epigenetic agent phenethyl isothiocyanate on growth inhibition, cell cycle arrest and apoptosis in breast cancer cells.
abstract: This study examined whether combining paclitaxel (taxol) with a novel epigenetic agent phenethyl isothiocyanate (PEITC) will yield a synergistic effect on inhibiting breast cancer cells. Two drug-resistant breast cancer cell lines, MCF7 and MDA-MB-231, were treated with PEITC and taxol. Cell growth, cell cycle, and apoptosis were examined. The combination of PEITC and taxol significantly decreased the IC50 of PEITC and taxol over each agent alone. The combination also increased apoptosis by more than two fold over each single agent in both cell lines. A significant increase of cells in the G2/M phases was detected. In conclusion, the combination of PEITC and taxol exhibits a synergistic effect on growth inhibition in breast cancer cells. This combination deserves further study in vivo.
authors: Department of Medicine, New York Medical College, Valhalla, NY 10595, USA.
authors: Katherine
authors: K
authors: Liu
authors: Department of Oncology, Henan Province People's Hospital, Zhengzhou, China.
authors: Shundong
authors: S
authors: Cang
authors: Department of Oncology, Henan Province People's Hospital, Zhengzhou, China.
authors: Yuehua
authors: Y
authors: Ma
authors: Department of Medicine, New York Medical College, Valhalla, NY 10595, USA.
authors: Jen Wei
authors: JW
authors: Chiao
references: Science. 1999 Oct 15;286(5439):481-6
references: 10521337
references: Semin Oncol. 2005 Oct;32(5):443-51
references: 16210084
references: Curr Cancer Drug Targets. 2007 Dec;7(8):730-42
references: 18220533
references: Annu Rev Biochem. 1998;67:545-79
references: 9759497
references: Int J Oncol. 2008 Aug;33(2):375-80
references: 18636159
references: Cancer Treat Rep. 1978 Aug;62(8):1219-22
references: 688258
references: J Biol Chem. 1981 Oct 25;256(20):10435-41
references: 6116707
references: Cancer Treat Rep. 1987 Dec;71(12):1179-84
references: 2891442
references: Cell. 1999 Nov 24;99(5):451-4
references: 10589672
references: J Clin Oncol. 1987 Aug;5(8):1232-9
references: 2887641
references: Proc Natl Acad Sci U S A. 1995 May 9;92(10):4507-11
references: 7753834
references: Cancer Treat Rep. 1987 Dec;71(12):1171-7
references: 2891441
references: Oncol Rep. 2006 Dec;16(6):1363-7
references: 17089062
references: Exp Hematol Oncol. 2012 Jun 18;1(1):14
references: 23210689
references: J Hematol Oncol. 2012 Nov 09;5:70
references: 23140144
references: Curr Med Chem. 2007;14(28):3035-45
references: 18220739
references: J Natl Cancer Inst. 1991 Dec 18;83(24):1797-805
references: 1683908
references: Anticancer Res. 2006 Mar-Apr;26(2A):1225-30
references: 16619528
references: Cancer Res. 1987 May 1;47(9):2486-93
references: 2882837
references: Clin Cancer Res. 2005 May 15;11(10):3604-8
references: 15897554
references: Proc Natl Acad Sci U S A. 1980 Mar;77(3):1561-5
references: 6103535
references: Mol Cell Biol. 1998 Aug;18(8):4629-38
references: 9671473
references: Biochemistry. 1981 May 26;20(11):3247-52
references: 6113842
references: Eur J Biochem. 1981 Mar 16;115(1):207-16
references: 7227366
references: J Hematol Oncol. 2008 Jun 09;1:6
references: 18577263
references: J Hematol Oncol. 2011 Jan 13;4:3
references: 21232120
references: Exp Hematol Oncol. 2012 Nov 29;1(1):36
references: 23210908
references: Int J Oncol. 2006 May;28(5):1287-93
references: 16596246
references: J Hematol Oncol. 2012 Dec 06;5:72
references: 23216927
references: Hum Mol Genet. 2001 Apr;10(7):693-8
references: 11257101
references: Exp Hematol Oncol. 2012 Apr 05;1(1):4
references: 23210930
references: J Am Chem Soc. 1971 May 5;93(9):2325-7
references: 5553076
references: J Clin Oncol. 1991 Jul;9(7):1261-7
references: 1675263
references: J Natl Cancer Inst. 1993 Jun 2;85(11):892-7
references: 8492317
references: Cell. 1999 Nov 24;99(5):443-6
references: 10589670
references: Curr Top Microbiol Immunol. 2000;249:55-74
references: 10802938
references: Mol Carcinog. 2007 Jan;46(1):24-31
references: 16921492
references: Nature. 1979 Feb 22;277(5698):665-7
references: 423966
references: Cancer Cell. 2006 Sep;10(3):241-52
references: 16959615
references: Ann Intern Med. 1989 Aug 15;111(4):273-9
references: 2569287
references: J Hematol Oncol. 2011 Apr 20;4:16
references: 21504625
references: Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3578-88
references: 14506144
references: Exp Hematol Oncol. 2012 Dec 10;1(1):38
references: 23227884
references: EMBO J. 1997 Apr 15;16(8):2096-107
references: 9155035
references: J Hematol Oncol. 2012 Jul 02;5:36
references: 22747680
references: Br J Cancer. 1993 Dec;68(6):1104-9
references: 7903152
references: Exp Hematol Oncol. 2012 Apr 23;1(1):10
references: 23210520
references: Int J Oncol. 2009 Dec;35(6):1417-22
references: 19885564